Cosmetics · Quasi-drug actives

Dipotassium Glycyrrhizate

グリチルリチン酸2K (Guricchirurichin-san 2 K)

Also known as: Glycyrrhizinate Dipotassium

Looking for a Japanese supplier of Dipotassium Glycyrrhizate? Tell us

At a glance

CategoryCosmetics
INCI nameDipotassium Glycyrrhizate
Japanese labeling nameグリチルリチン酸2K
Common Japanese notationsグリチルリチン酸2K, グリチルリチン酸ジカリウム
CAS number68797-35-3
OriginPlant-derived (Glycyrrhiza root, processed to dipotassium salt)
Typical functionsQuasi-drug anti-inflammatory active
Regulatory status in JapanApproved as a quasi-drug (医薬部外品) anti-inflammatory active by 厚生労働省 (Ministry of Health, Labour and Welfare). Permitted across multiple product category claims.

Dipotassium glycyrrhizate is the water-soluble dipotassium salt of glycyrrhizic acid, the major glycoside from licorice (Glycyrrhiza) root. It is one of the most-used quasi-drug anti-inflammatory active ingredients in Japan, appearing across medicated skincare, oral care, and bath products.

Find OEM manufacturers

Browse Japanese OEM manufacturers that build products in this category. Filter by small lot, certifications, prefecture.

Classification

Tags below link to other ingredients sharing the same attribute, so you can pivot from one ingredient to its peers.

Common OEM product categories

Finished-product categories where Japanese OEM manufacturers commonly formulate with this ingredient.

  • Medicated sensitive-skin lines
  • Medicated acne products (薬用ニキビケア)
  • Quasi-drug oral care
  • Quasi-drug bath products

Ingredient profile

Dipotassium glycyrrhizate is produced by salt exchange from glycyrrhizic acid extracted from Glycyrrhiza root. The water-soluble dipotassium form is preferred for aqueous cosmetic formulations.

OEM applications

In Japanese cosmetics, dipotassium glycyrrhizate appears in sensitive-skin lines, anti-acne products, sunscreens marketed for sensitive skin, oral care, and bath products.

Regulatory classification in Japan

Approved as a quasi-drug anti-inflammatory active by 厚生労働省 (Ministry of Health, Labour and Welfare).

Regulatory classification in other markets

EUListed in CosIng. Permitted for cosmetic use.
USAINCI recognized.
ChinaPermitted per IECIC listings.
KoreaPermitted under KFDA / MFDS.

Market reference formulations

Example finished products will be added after each product's current full ingredient list has been verified.

All brand names and product names referenced anywhere on this site are the property of their respective owners. Example entries are provided for informational purposes only and do not imply endorsement.

Typical OEM use levels

Formulation ranges per finished-product application. Verify against the cited source before production.

ApplicationTypical rangeRegulatory limitNotes
Quasi-drug anti-inflammatory skin / oral / scalp products (Japan)0.05–0.2%Capped per 厚生労働省 quasi-drug notification per productApproved as 抗炎症 active in 医薬部外品(厚生労働省 医薬部外品有効成分通知)

Stability & compatibility

pH range
pH 5.0–9.0 (broadly stable)
Temperature
Highly stable; tolerates standard hot- and cold-process formulation
Incompatibilities
  • Strong acids (dipotassium salt may precipitate at low pH)

Water-soluble dipotassium salt of glycyrrhizic acid; one of the most formulation-friendly anti-inflammatory actives in Japanese cosmetics.

Alternative ingredients

Related ingredients commonly evaluated as substitutes.

Quick answers

What is Dipotassium Glycyrrhizate?
Dipotassium glycyrrhizate is the water-soluble dipotassium salt of glycyrrhizic acid, the major glycoside from licorice (Glycyrrhiza) root. It is one of the most-used quasi-drug anti-inflammatory active ingredients in Japan, appearing across medicated skincare, oral care, and bath products.
What is the regulatory status of Dipotassium Glycyrrhizate in Japan?
Approved as a quasi-drug (医薬部外品) anti-inflammatory active by 厚生労働省 (Ministry of Health, Labour and Welfare). Permitted across multiple product category claims.
What products typically use Dipotassium Glycyrrhizate?
Medicated sensitive-skin lines / Medicated acne products (薬用ニキビケア) / Quasi-drug oral care / Quasi-drug bath products
Where does Dipotassium Glycyrrhizate come from?
Plant-derived (Glycyrrhiza root, processed to dipotassium salt)
What is the INCI / JSCI labeling name for Dipotassium Glycyrrhizate?
INCI: Dipotassium Glycyrrhizate / JSCI: グリチルリチン酸2K

FAQ for OEM buyers

Q. Is dipotassium glycyrrhizate approved as a quasi-drug active in Japan?

Yes — it is on the 厚生労働省 (Ministry of Health, Labour and Welfare) quasi-drug active ingredient list as an anti-inflammatory active (抗炎症) used in medicated acne, sensitive-skin, oral care, and bath products. Quasi-drug claims around skin irritation and acne require quasi-drug notification.

Sources · Last reviewed: 2026-04-26

  • 厚生労働省 (Ministry of Health, Labour and Welfare) — quasi-drug anti-inflammatory actives (dipotassium glycyrrhizate)
Q. What is the typical use level and pH compatibility?

Used at 0.05–0.5% in cosmetic anti-inflammatory positioning and up to ~0.3% in medicated quasi-drugs; freely water-soluble and stable across pH 5–8. Above pH 8 or with certain cationic surfactants, precipitation can occur.

Sources · Last reviewed: 2026-04-26

  • Industry knowledge — dipotassium glycyrrhizate formulation practice

Industry-knowledge claim — not yet pinned to a single primary source

Q. What is the source of the ingredient?

It is the dipotassium salt of glycyrrhizic acid extracted from licorice (Glycyrrhiza glabra/uralensis) root. Buyers commonly request a non-GMO and pesticide-residue spec at qualification.

Sources · Last reviewed: 2026-04-26

  • Industry knowledge — licorice extract sourcing

Industry-knowledge claim — not yet pinned to a single primary source

Q. Are there export restrictions or allergen concerns?

There are no major regulatory restrictions in Japan, EU, US, or China; dipotassium glycyrrhizate is on China's IECIC inventory and is broadly accepted. Allergen disclosure is not required.

Sources · Last reviewed: 2026-04-26

  • China NMPA — IECIC inventory

Use cases

  • Medicated acne lotion (薬用ニキビケア化粧水)

    Positioning
    Anti-inflammatory acne care quasi-drug
    Typical usage level
    0.1–0.3% (Japan quasi-drug)
    Formulation notes
    Combined with salicylic acid or IPMP; pH 5–7 water phase.

    Sources

    • Industry knowledge — Japanese medicated acne segment

    Industry-knowledge claim — not yet pinned to a single primary source

  • Sensitive-skin moisturizer

    Positioning
    Daily-use sensitive-skin lotion / cream
    Typical usage level
    0.05–0.2%
    Formulation notes
    Combined with ceramides, panthenol, and allantoin for soothing claims.

    Sources

    • Industry knowledge — sensitive-skin formulation

    Industry-knowledge claim — not yet pinned to a single primary source

  • Oral care (medicated toothpaste / mouthwash)

    Positioning
    Anti-inflammatory gum-care quasi-drug
    Formulation notes
    Used at 0.05–0.2% in toothpaste and mouthwash; quasi-drug filing for gum-inflammation claims.

    Sources

    • Industry knowledge — Japanese medicated oral-care category

    Industry-knowledge claim — not yet pinned to a single primary source

  • Sensitive-skin sunscreen

    Positioning
    Sensitive-skin / baby-friendly sunscreen
    Formulation notes
    Used at 0.05–0.2% in mineral sunscreen base; combined with allantoin.

    Sources

    • Industry knowledge — sensitive-skin sunscreen formulation

    Industry-knowledge claim — not yet pinned to a single primary source

  • Medicated bath additive

    Positioning
    Soothing bath-tablet / bath salt for sensitive skin
    Formulation notes
    Water-soluble; combined with sodium bicarbonate and other bath actives.

    Sources

    • Industry knowledge — Japanese medicated bath-additive segment

    Industry-knowledge claim — not yet pinned to a single primary source

Search the academic literature

Pre-filled queries for the major research databases. Opens in a new tab.

Official regulatory databases

External links to public Japanese / international regulatory authorities. We are not affiliated.

References

  1. Japan 医薬品医療機器総合機構 PMDA (Pharmaceuticals and Medical Devices Agency) — quasi-drug active ingredient approval registry
  2. EU CosIng entry: Dipotassium Glycyrrhizate

Last updated: 2026-04-22. Ingredient entries are reviewed at least annually against current regulatory listings.

Explore more Japan-market resources

Related tools for overseas buyers, formulators, and sourcing teams.